CIP
CDLX icon

CAS Investment Partners’s Cardlytics CDLX Stock Holding History

CAS Investment Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46M Hold
519,807
– – 0.31% 4
2025
Q4 		$5.98M Hold
519,807
– – 0.26% 5
2025
Q3 		$12.6M Sell
519,807
-41,585
-7% -$693K 0.56% 4
2025
Q2 		$9.23M Hold
561,392
– – 0.45% 4
2025
Q1 		$10.2M Sell
561,392
-75,499
-12% -$2.16M 0.66% 4
2024
Q4 		$23.6M Sell
636,891
-5,082
-0.8% -$194K 1.38% 4
2024
Q3 		$20.5M Sell
641,973
-4,513
-0.7% -$250K 1.36% 4
2024
Q2 		$53.1M Buy
646,486
+9,118
+1% +$986K 4.15% 4
2024
Q1 		$92.4M Buy
637,368
+95,756
+18% +$8.09M 8.28% 4
2023
Q4 		$49.9M Hold
541,612
– – 6.03% 5
2023
Q3 		$89.4M Hold
541,612
– – 11.46% 4
2023
Q2 		$34.2M Hold
541,612
– – 5.21% 5
2023
Q1 		$18.4M Hold
541,612
– – 3.77% 5
2022
Q4 		$31.3M Hold
541,612
– – 7.48% 4
2022
Q3 		$50.9M Hold
541,612
– – 9.29% 4
2022
Q2 		$121M Hold
541,612
– – 18.32% 3
2022
Q1 		$298M Buy
541,612
+22,965
+4% +$13.9M 19.93% 3
2021
Q4 		$343M Buy
518,647
+3,688
+0.7% +$2.82M 17.89% 3
2021
Q3 		$432M Buy
514,959
+66,062
+15% +$67M 20.6% 2
2021
Q2 		$570M Hold
448,897
– – 24.24% 2
2021
Q1 		$492M Hold
448,897
– – 25.16% 2
2020
Q4 		$641M Buy
448,897
+9,738
+2% +$10.4M 35.51% 2
2020
Q3 		$310M Buy
439,159
+37,734
+9% +$27.4M 21.48% 2
2020
Q2 		$281M Buy
401,425
+6,273
+2% +$3.62M 30.25% 2
2020
Q1 		$138M Buy
395,152
+112,981
+40% +$80M 30.38% 2
2019
Q4 		$177M Buy
282,171
+50,230
+22% +$24.6M 29.17% 2
2019
Q3 		$77.7M Buy
231,941
+15,739
+7% +$5.05M 17.17% 3
2019
Q2 		$56.2M Buy
+216,202
New +$43.3M 14.39% 3

Other funds holding CDLX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

CAS Investment Partners's CDLX Position: Q1 2026 in Review

CAS Investment Partners held its Cardlytics (CDLX) position steady in Q1 2026 at 519,807 shares worth $5.46M. The position accounts for 0.31% of the portfolio, ranked #4.

CAS Investment Partners first reported a position in CDLX in Q2 2019 and has held it in 28 quarters since. The position peaked at $641M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • CAS Investment Partners held 519,807 shares of Cardlytics worth $5.46M as of Q1 2026.
  • CAS Investment Partners left its Cardlytics share count unchanged in Q1 2026.
  • Cardlytics made up 0.31% of CAS Investment Partners's portfolio in Q1 2026, its #4 holding.
  • CAS Investment Partners first reported a position in Cardlytics in Q2 2019 and has held it in 28 quarters since.
  • CAS Investment Partners's Cardlytics position peaked at $641M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on CAS Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.